系统性硬化症相关间质性肺病:亚临床、临床和进展性疾病的概念框架
研究向83名专家提供亚临床、临床和进展性间质性肺病的概念框架,要求其对系统性硬化症相关间质性肺病患者进行分类。44名专家(53%)完成调查,在疾病严重程度(75%,80例中60例)、进展风险(71%,80例中57例)和进展性间质性肺病(60%,40例中24例)维度达成共识。达成共识的病例多被分类为临床间质性肺病(92%)、低风险(54%)和稳定(71%);严重程度和疾病进展在分类中最具影响力的框架条目上存在重叠(用力肺活量、高分辨率胸部CT上的肺部受累范围),进展风险主要受疾病病程影响。
要点
- 国际专家使用所提出的概念框架在疾病严重程度、进展风险和随时间进展三个维度对SSc-ILD患者分类达成共识。
- 严重程度共识为75%(80例中60例),进展风险共识为71%(80例中57例),进展性ILD共识为60%(40例中24例)。
- 达成共识的病例多分类为临床ILD(92%)、低风险(54%)和稳定(71%);严重程度与进展分类均依赖用力肺活量和高分辨率胸部CT肺部受累范围。
核心结论
- 使用所提出的概念框架,国际专家能够在疾病严重程度、进展风险和随时间进展维度对SSc-ILD患者分类达成共识。
- 专家在分类疾病严重程度和进展时依赖相似的条目:肺功能检查和气体交换与定量高分辨率胸部CT的组合。
研究设计与样本
- 向83名专家提供亚临床、临床和进展性间质性肺病的概念框架,要求其使用该框架对实际SSc-ILD患者进行分类。
- 每个患者档案设计为至少由四名专家在基线时根据严重程度和进展风险进行分类;进展基于1年随访数据。
- 若≥75%的专家意见一致则视为达成共识;专家提供哪些条目对确定分类重要的信息。
- 44名专家(53%)完成了调查。
主要发现
- 在严重程度维度达成共识(75%,80例档案中60例),进展风险维度达成共识(71%,80例档案中57例),进展性ILD维度达成共识(60%,40例档案中24例)。
- 对于达成共识的档案,多数被分类为临床ILD(92%)、低风险(54%)和稳定(71%)。
- 严重程度和疾病进展在分类患者时最具影响力的框架条目上存在重叠(用力肺活量、高分辨率胸部CT上的肺部受累范围);进展风险主要受疾病病程影响。
关键数值与推荐
- 共识阈值:≥75%的专家意见一致。
- 严重程度共识:75%(80例档案中60例)。
- 进展风险共识:71%(80例档案中57例)。
- 进展性ILD共识:60%(40例档案中24例)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD). METHODS: A conceptual framework for subclinical, clinical and progressive ILD was provided to 83 experts, asking them to use the framework and classify actual SSc-ILD patients. Each patient profile was designed to be classified by at least four experts in terms of severity and risk of progression at baseline; progression was based on 1-year follow-up data. A consensus was reached if ≥75% of experts agreed. Experts provided information on which items were important in determining classification. RESULTS: Forty-four experts (53%) completed the survey. Consensus was achieved on the dimensions of severity (75%, 60 of 80 profiles), risk of progression (71%, 57 of 80 profiles) and progressive ILD (60%, 24 of 40 profiles). For profiles achieving consensus, most were classified as clinical ILD (92%), low risk (54%) and stable (71%). Severity and disease progression overlapped in terms of framework items that were most influential in classifying patients (forced vital capacity, extent of lung involvement on high resolution chest CT [HRCT]); risk of progression was influenced primarily by disease duration. CONCLUSIONS: Using our proposed conceptual framework, international experts were able to achieve a consensus on classifying SSc-ILD patients along the dimensions of disease severity, risk of progression and progression over time. Experts rely on similar items when classifying disease severity and progression: a combination of spirometry and gas exchange and quantitative HRCT.
引用
- Roofeh D, Brown KK, Kazerooni EA, et al. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford). 2023. PMID: 36173318. doi:10.1093/rheumatology/keac557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。